Menu

Merino Sheep Provide Clue to Curly Hair

The cells on one side of each wool fiber are longer than the cells on the other, researchers find. 

Mar 23, 2018
Catherine Offord

ISTOCK, JOHNCARNEMOLLAHairs curl because the cells on one side of the strand are longer than the cells on the other, at least in merino sheep, according to a study published today (March 23) in the Journal of Experimental Biology. The findings don’t fit neatly into either of the two leading theories for how curliness arises—namely, that there are more cells on one side than another, or that the two main cell types making up hair differ consistently in length and are distributed unevenly.

“We went in to test those two theories because as it turns out no-one has been able to directly measure them before,” study coauthor Duane Harland of agricultural research institute AgResearch in New Zealand tells ABC News. He adds that “it was very fiddly because the pieces of wool you’re dealing with are incredibly small.”

To analyze the fibers, Harland and his colleagues teamed up with a Japanese cosmetic company, Kao Corporation. After cleaning and separating hundreds of tiny cuttings of merino sheep wool, the researchers measured the curvature of each fiber, and then observed the wool under a microscope.

They found that although the two cell types, known as orthocortical and paracortical cells, did indeed differ in length on average, there was a wide range of lengths in both cell types, and the average difference could not predict the curvature of the fibers.

Instead, the team showed that curvature was determined by the relative length of an orthocortical cell and the paracortical cell directly opposite it—meaning a mix of the two previous theories can explain why hair curls. “We have established clearly that cell type is important, as is cell length,” Harland tells The New Zealand Herald. The same should be true for human hair, he adds.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.